The anoikis effector Bit1 displays tumor suppressive function in lung cancer cells

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• Anoikis resistance is crucial for cancer cell transformation and tumorigenesis.
• The mitochondrial protein Bit1 (Bcl-2 inhibitor of transcription 1) acts as an anoikis effector, inducing caspase-independent apoptosis upon loss of cell attachment.
• Cancer cells may evade the Bit1-mediated apoptotic pathway to achieve anchorage-independence.

Purpose of the Study:

• To investigate the tumor suppressive role of Bit1 in lung adenocarcinoma.
• To elucidate the mechanism by which Bit1 induces anoikis and its implication in anchorage-independent growth.
• To explore the interaction between Bit1, TLE1, and AES in the context of lung cancer.

Main Methods:

• Restitution of Bit1 expression in anoikis-resistant A549 lung adenocarcinoma cells.
• Stable downregulation of Bit1 in A549 cells.
• Assessment of anoikis induction, caspase activation, and anchorage-independent growth.
• In vivo tumorigenicity assays in Bit1 knockdown cells.
• Investigation of the interaction between Bit1, TLE1, and AES.

Main Results:

• Restoring Bit1 in A549 cells induced anoikis and impaired anchorage-independent growth, even with defective caspase activation.
• Downregulating Bit1 enhanced anoikis resistance and anchorage-independent growth in A549 cells.
• Bit1 knockdown cells exhibited increased tumorigenicity in vivo.
• The nuclear corepressor TLE1 was found to block Bit1-mediated anoikis by sequestering AES in the nucleus.
• Bit1 was observed to be downregulated in human non-small cell lung cancer (NSCLC) tissues.

Conclusions:

• Bit1 acts as a tumor suppressor in lung cancer by inducing caspase-independent anoikis.
• TLE1-mediated sequestration of AES contributes to anoikis resistance in lung cancer.
• Downregulation of Bit1 is associated with increased tumorigenicity and is observed in human NSCLC tissues, supporting its role as a tumor suppressor.